Top Story

ARISTOTLE: Major bleeding consequences similar between apixaban, warfarin

December 22, 2014

Major bleeding was associated with increased risk for death, ischemic stroke and MI, and the risk was similarly elevated regardless of treatment with warfarin or apixaban, according to new findings from the ARISTOTLE trial.

Researchers conducted an ancillary study from ARISTOTLE, the pivotal trial for apixaban (Eliquis, Bristol-Myers Squibb/Pfizer; n=18,201) to evaluate the clinical consequences of major bleeds and to compare the management and treatment effects of warfarin vs. apixaban.

Deborah Young In the JournalsPerspective

Self-reported exercise assessments offer clue to cardiometabolic risks

December 22, 2014
Clinicians could glean additional information about patients’ cardiometabolic risk factors through routine clinical physical activity assessments, according to…
Hans-Christoph Diener, MD, PhD

New trial will assess dabigatran for prevention of recurrent stroke

December 21, 2014
The first patient has been enrolled in the RE-SPECT ESUS study, which will investigate the safety of dabigatran etexilate for the prevention of recurrent embolic stroke…

CVD care improved across US hospitals from 2009 to 2013

December 20, 2014
The quality of care for patients with MI, HF, stroke and venous thromboembolism has improved across hospitals in the United States in recent years, according to an…
In the Journals

Stressful duties increased sudden cardiac death risk for police officers

December 19, 2014
Police officers engaged in stressful law enforcement duties such as suspect pursuits or rescue operations had a greater risk for sudden cardiac death compared with…
More News Headlines »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
Meeting News Coverage Video
Healio AHA2014 Bhatt1 th

VIDEO: Deepak L. Bhatt, MD, MPH, discusses 'practice-changing' IMPROVE-IT results

December 14, 2014
CHICAGO — The "practice-changing" results from the IMPROVE-IT trial presented at the American Heart Association…
More »
CME
Lipid Forum II Highlights

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
morganatic-roan
morganatic-roan